Igor Matushansky
Impact in
-
- Sarcoma Diagnosis and Treatment
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
-
- Sarcoma Diagnosis and Treatment 16
- Oncology 6
- Cancer-related Molecular Pathways 4
- Co-authors
- Sara Siddiqi (5 shared papers)Carlos Cordon‐Cardo (8 shared papers)Arthur I. Skoultchi (6 shared papers)Joslyn E. Mills (7 shared papers)Elizabeth Charytonowicz (6 shared papers)Farshid Radparvar (4 shared papers)Filemon S. Dela Cruz (4 shared papers)Robert G. Maki (6 shared papers)
- Journals
- Blood (2 papers)Journal of Clinical Investigation (2 papers)Oncogene (2 papers)Nature Medicine (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Igor Matushansky
32 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 70
- Pulmonary and Respiratory Medicine 565
- Genetics 150
- Cancer Research 221
- Oncology 287
- Hematology 172
Countries citing papers authored by Igor Matushansky
This map shows the geographic impact of Igor Matushansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Matushansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Matushansky more than expected).
Fields of papers citing papers by Igor Matushansky
This network shows the impact of papers produced by Igor Matushansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Matushansky. The network helps show where Igor Matushansky may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Matushansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 238 | |
| 2 | 2007 | 162 | |
| 3 | 2011 | 144 | |
| 4 | 2009 | 127 | |
| 5 | 2008 | 113 | |
| 6 | 2012 | 109 | |
| 7 | 2012 | 102 | |
| 8 | 2000 | 95 | |
| 9 | 2003 | 88 | |
| 10 | 2000 | 76 | |
| 11 | 2012 | 72 | |
| 12 | 2003 | 71 | |
| 13 | 2008 | 67 | |
| 14 | 2012 | 57 | |
| 15 | 2000 | 48 | |
| 16 | 2010 | 36 | |
| 17 | Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1. | 2003 | 34 |
| 18 | MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas. | 2011 | 26 |
| 19 | 2005 | 19 | |
| 20 | 2009 | 18 |
About Igor Matushansky
Igor Matushansky is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Hematology and Genetics, having authored 35 papers that have together received 1.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (16 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (4 papers), Immunotherapy and Immune Responses (3 papers), Acute Myeloid Leukemia Research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Virus-based gene therapy research (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (565 citations), Genetics (150 citations), Cancer Research (221 citations), Oncology (287 citations) and Hematology (172 citations). Igor Matushansky has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Sara Siddiqi, Carlos Cordon‐Cardo, Arthur I. Skoultchi, Joslyn E. Mills, Elizabeth Charytonowicz, Farshid Radparvar, Filemon S. Dela Cruz, Robert G. Maki, Eva Hernando and Nicholas D. Socci. Their work appears in journals such as Blood, Journal of Clinical Investigation, Oncogene, Nature Medicine and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.